Body Composition

Retatrutide and Calorie Intake

How does retatrutide affect calorie intake? This page reviews what the evidence shows about energy balance, appetite suppression, glucagon receptor effects, and caloric management during treatment.

How Retatrutide Affects Energy Balance

GLP-1 receptor agonism

Reduces appetite and food intake; slows gastric emptying; increases satiety signals

GIP receptor agonism

Potentiates insulin secretion; may contribute to fat metabolism and appetite regulation

Glucagon receptor agonism

Increases energy expenditure; reduces hepatic fat; adds to caloric deficit beyond appetite suppression alone

The Glucagon Difference

Unlike semaglutide (GLP-1 only) or tirzepatide (GLP-1 + GIP), retatrutide adds glucagon receptor agonism. Glucagon increases energy expenditure and hepatic fat oxidation. This means retatrutide creates a caloric deficit through both reduced intake (appetite suppression) and increased expenditure (glucagon-mediated thermogenesis) — a dual mechanism not present in other approved GLP-1 class drugs.

Caloric Management Considerations

Retatrutide's strong appetite suppression can lead to very low caloric intake. While caloric restriction drives weight loss, extremely low intake can cause nutrient deficiencies, inadequate protein intake, and excessive lean mass loss. Physician-supervised caloric management is important during treatment.

Questions about retatrutide? A licensed physician can review your case.

Start Physician Review